Vital Sign and Biochemical Data Collection Using Non-contact Photoplethysmography and the Comestai Mobile Health App: Protocol for an Observational Study
JMIR Research Protocols · 2025
DOI: 10.2196/65229 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Gianvincenzo Zuccotti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Science, University of Milano, Milano, Italy. Hauptthemen laut MEDLINE: Photoplethysmography, Mobile Applications, Vital Signs, Data Collection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Early detection of vital sign changes is key to recognizing patient deterioration promptly, enabling timely interventions and potentially preventing adverse outcomes.
Objective
In this study, vital parameters (heart rate, respiratory rate, oxygen saturation, and blood pressure) will be measured using the Comestai app to confirm the accuracy of photoplethysmography methods compared to standard clinical practice devices, analyzing a large and diverse population. In addition, the app will facilitate big data collection to enhance the algorithm’s performance in measuring hemoglobin, glycated hemoglobin, and total cholesterol.
Methods
A total of 3000 participants will be consecutively enrolled to achieve the objectives of this study. In all patients, personal data, medical condition, and treatment overview will be recorded. The “by face” method for remote photoplethysmography vital sign data collection involves recording participants’ faces using the front camera of a mobile device (iOS or Android) for approximately 1.5 minutes. Simultaneously, vital signs will be continuously collected for about 1.5 minutes using the reference devices alongside data collected via the Comestai app; biochemical results will also be recorded. The accuracy of the app measurements compared to the reference devices and standard tests will be assessed for all parameters. CIs will be calculated using the bootstrap method. The proposed approach’s effectiveness will be evaluated using various quality criteria, including the mean error, SD, mean absolute error, root mean square error, and mean absolute percentage error. The correlation between measurements obtained using the app and reference devices and standard tests will be evaluated using the Pearson correlation coefficient. Agreement between pairs of measurements (app vs reference devices and standard tests) will be represented using Bland-Altman plots. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and likelihood ratios will be calculated to determine the ability of the new app to accurately measure vital signs.
Results
Data collection began in June 2024. As of March 25, 2025, we have recruited 1200 participants. The outcomes of the study are expected at the end of 2025. The analysis plan involves verifying and validating the parameters collected from mobile devices via the app, reference devices, and prescheduled blood tests, along with patient demographic data.
Conclusions
Our study will enhance and support the accuracy of data on vital sign detection through PPG, also introducing measurements of biochemical risk indicators. The evaluation of a large population will allow for continuous improvement in the performance and accuracy of artificial intelligence algorithms, reducing errors. Expanding research on mobile health solutions like Comestai can support preventive care by validating their effectiveness as screening tools and guiding future health care technology developments. Trial Registration ClinicalTrials.gov NCT06427564; https://clinicaltrials.gov/study/NCT06427564
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical and Clinical Science, University of Milano, Milano, Italy.
- Pediatric Department, Buzzi Children's Hospital, Milano, Italy.
- Come Stai S.p.A, Milano, Italy.
- Endocrine Diseases and Diabetology Unit, Azienda Socio Sanitaria Territoriale Fatebenefratelli Sacco, Milano, Italy.
- Diabetology and Endocrinology Unit, Istituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milano, Italy.
- Cardiac Rehabilitation Unit, Istituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milano, Italy.
ORCID-Profile: Gianvincenzo Zuccotti, Paolo Osvaldo Agnelli, Lucia Labati, Erika Cordaro, Davide Braghieri, Simone Balconi, Marco Xodo, Fabrizio Losurdo, Cesare Celeste Federico Berra, Roberto Franco Enrico Pedretti, Paolo Fiorina, Sergio Maria De Pasquale, Valeria Calcaterra
Zitieren
APA
Zuccotti, G., Agnelli, P. O., Labati, L., Cordaro, E., Braghieri, D., Balconi, S., Xodo, M., Losurdo, F., Berra, C. C. F., Pedretti, R. F. E., Fiorina, P., De Pasquale, S. M., & Calcaterra, V. (2025). Vital Sign and Biochemical Data Collection Using Non-contact Photoplethysmography and the Comestai Mobile Health App: Protocol for an Observational Study. JMIR Research Protocols. https://doi.org/10.2196/65229
Vancouver
Zuccotti G, Agnelli PO, Labati L, Cordaro E, Braghieri D, Balconi S, et al. Vital Sign and Biochemical Data Collection Using Non-contact Photoplethysmography and the Comestai Mobile Health App: Protocol for an Observational Study. JMIR Research Protocols. 2025. doi:10.2196/65229
BibTeX
@article{Zuccotti2025,
author = {Zuccotti, Gianvincenzo and Agnelli, Paolo Osvaldo and Labati, Lucia and Cordaro, Erika and Braghieri, Davide and Balconi, Simone and Xodo, Marco and Losurdo, Fabrizio and Berra, Cesare Celeste Federico and Pedretti, Roberto Franco Enrico and Fiorina, Paolo and De Pasquale, Sergio Maria and Calcaterra, Valeria},
title = {Vital Sign and Biochemical Data Collection Using Non-contact Photoplethysmography and the Comestai Mobile Health App: Protocol for an Observational Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/65229}
}
EUVIMED